We observed a trend towards decreased neurofilament immunoreactivity in the Down syndrome spleen (Supplementary Fig. 2a–c) and pancreas (Supplementary Fig. 2f–h), although these deficits were not as severe as the decreases in TH immunoreactivity, and were not statistically different from control tissues. This evidence concerns the gene TH and Down syndrome.